Pacific Biosciences of California, Inc. Stock
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.560 USD | -3.11% |
|
-7.14% | -16.58% |
| Market Cap | 485M 424M 391M 361M 685M 46.21B 697M 4.67B 1.83B 22.77B 1.82B 1.78B 78.26B | P/E 2026 * |
-3.8x | P/E 2027 * | -3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 485M 424M 391M 361M 685M 46.21B 697M 4.67B 1.83B 22.77B 1.82B 1.78B 78.26B | EV / Sales 2026 * |
2.89x | EV / Sales 2027 * | 2.5x |
| Free-Float |
91.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | -3.11% | ||
| 1 week | -7.14% | ||
| Current month | -7.14% | ||
| 1 month | +13.87% | ||
| 3 months | +16.42% | ||
| 6 months | -19.59% | ||
| Current year | -16.58% |
| 1 week | 1.48 |  | 1.72 |
| 1 month | 1.3 | | 1.84 |
| Current year | 1.09 | | 2.73 |
| 1 year | 1.09 | | 2.73 |
| 3 years | 0.85 | | 14.55 |
| 5 years | 0.85 | | 35.58 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 14/09/2020 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 31/03/2025 |
Mark van Oene
COO | Chief Operating Officer | 53 | 08/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 01/01/2004 |
Randy Livingston
BRD | Director/Board Member | 72 | 01/01/2009 |
Marshall Mohr
BRD | Director/Board Member | 69 | 18/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Free | Director | 223,492 | 0.0720% | ||
| 06-03 | Free | Director | 74,497 | 0.0240% | ||
| 06-03 | Free | Director | 223,492 | 0.0720% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.11% | -7.14% | +4.00% | -88.44% | 485M | |
| +0.45% | +0.69% | +22.36% | +1.97% | 196B | |
| -1.16% | -4.51% | -22.67% | +19.55% | 144B | |
| +1.57% | +0.57% | -3.14% | -15.11% | 141B | |
| -0.49% | -0.82% | -56.89% | -15.05% | 66.54B | |
| +0.96% | -2.29% | +17.02% | +0.62% | 53.09B | |
| +0.61% | -1.09% | -27.71% | -30.42% | 44.12B | |
| +0.52% | +2.75% | +8.15% | +13.46% | 37.93B | |
| -0.19% | -0.75% | +6.55% | +42.23% | 36.96B | |
| -2.20% | -2.75% | -21.00% | -5.88% | 29.41B | |
| Average | +0.10% | -1.32% | -7.33% | -7.71% | 74.94B | |
| Weighted average by Cap. | +0.74% | -1.02% | -4.67% | +0.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 168M 147M 135M 125M 237M 16.01B 241M 1.62B 635M 7.88B 630M 616M 27.11B | 194M 170M 156M 144M 274M 18.49B 279M 1.87B 734M 9.11B 728M 712M 31.31B |
| Net income | -129M -112M -104M -95.8M -182M -12.26B -185M -1.24B -487M -6.04B -483M -472M -20.77B | -149M -130M -120M -111M -210M -14.17B -214M -1.43B -563M -6.98B -558M -546M -24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $1.560 | -3.11% | 6,685,600 |
| 09/07/26 | $1.610 | +7.33% | 6,137,150 |
| 08/07/26 | $1.500 | -3.85% | 4,142,714 |
| 07/07/26 | $1.560 | -6.02% | 3,669,266 |
| 06/07/26 | $1.660 | -1.19% | 3,892,813 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
